NCT01777620 - A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 29, 2013

Study Completion Date

July 31, 2013

Conditions

Facial Rhytides

Interventions

BIOLOGICAL

onabotulinumtoxinA

BOTOX® (onabotulinumtoxinA) injected into the areas of glabellar lines and crow's feet lines on Day 1.

DRUG

Normal Saline

Placebo (normal saline) injected into the areas of glabellar lines and crow's feet lines on Day 1.

Trial Locations (1)

Toronto